Cryo-Cell International Inc. (CCEL) is a publicly traded Healthcare sector company. As of October 6, 2026, CCEL trades at $3.70 with a market cap of $32.17M and a P/E ratio of -13.27. CCEL moved -1.62% today. Year to date, CCEL is +9.12%; over the trailing twelve months it is -18.10%. Its 52-week range spans $2.72 to $8.20. Rallies surfaces CCEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CCEL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CCEL recently traded at $3.70. Market cap is $32.17M. P/E ratio is -13.27. Revenue is $31.57M.
| Metric | Value |
|---|---|
| Price | $3.70 |
| Market Cap | $32.17M |
| P/E Ratio | -13.27 |
| EPS | $-0.30 |
| Dividend Yield | 0.15% |
| 52-Week High | $8.20 |
| 52-Week Low | $2.72 |
| Volume | 9.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $31.57M |
| Net Income | $-2.43M |
| Gross Margin | 76.63% |
CCEL analyst coverage data. Average price target: $0.00.